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Senescence is associated with gradual impairment of 
physiological processes, although the functions of the 
immune cell types may not be uniformly suppressed 
(Kogut et al., 2012; Sansoni et al., 2008; Scholz et al., 
2013). The immune ageing is correlated with preferen-
tial diminution of the T-cell compartment, increased 
ratio of the memory cell phenotype and lower CD28 
expression (Simioni et al., 2007). Although B cells from 
aged mice show decreased antigen-induced expansion, 
the ability of aged B cells to respond appropriately to 
T-dependent antigens and differentiate into antibody-
secreting cells seems to be intact (Dailey et al., 2001). 
In aged humans, the antigen-presenting function of 
peripheral blood cells in response to staphylococcal 
enterotoxin is poor in comparison to young individu-
als (Castle et al., 1999). The susceptibility to viral infec-
tions in old animals has been a subject of consideration. 
Twenty two to twenty four month old mice, infected 
with respiratory syncytial virus, demonstrated dimin-
ished virus specific CD8+ cytolytic response and IFN 
γ production (Zhang et al., 2002). In elderly human 
donors, the majority of the clonally expanded, virus-
specific CD8+ cells, was dysfunctional (Ouyang et al., 
2003). However, the frequency of viral antigen-spe-
cific CD8+ T cells was high in the majority of subjects 
older than 85 years and serologically positive for the 
viral epitopes (Scholz et al., 2013). These data indicate 
importance of a chronic antigenic stimulation, induced 
by persistent viral infections during a lifetime that may 
result in enhanced resistance to viral infections. 
Lactoferrin is a multifunctional protein, present in 
excretory fluids and circulating neutrophils, involved 
in iron metabolism (Zimecki and Kruzel, 2007). The 
protein interferes with viral infection by means of sev-
eral mechanisms, such as inhibition of virus replication 
and direct interaction with viruses (Välimaa et al., 2009; 
Picard-Jean et al., 2014) or blocking cell receptors for 
viruses (Pietroantoni et al., 2015; Zheng et al., 2012). 
The aim of this study was to compare the suscepti- 
bility of splenocytes from young versus aged organisms 
to viral infection and to investigate antiviral actions 
of a  homologous, recombinant mouse and native 
bovine lactoferrin.
Three and 13 months old CBA mice, provide by the 
institute of Laboratory Medicine, Łódź, Poland, were 
used for the study. The local ethics committee approved 
the study. Low endotoxin (< 1.0 EU/mg) recombinant 
mouse lactoferrin (rmLF) produced by Chinese hamster 
ovary cells was obtained from PharmaReview Corpora-
tion, Houston, USA, and bovine milk-derived lactoferrin 
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We compared the susceptibility to viral infection of splenocytes, isolated from young versus old CBA mice, and evaluated the antiviral 
actions of lactoferrin in splenocytes infected with Encephalomyocarditis virus (EMCV). Recombinant mouse lactoferrin (rmLF) and bovine 
lactoferrin (bLF) were used. There were no differences in the susceptibility to EMCV infection in the studied age categories. Both types of 
lactoferrins were protective in young and old mice. The study confirmed the undisturbed viral resistance in old mice and the protective 
actions of lactoferrin in viral infection. The antiviral action of the homologous mouse lactoferrin was demonstrated for the first time.
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(bLF) was generously provided by Morinaga Co., Japan. 
The culture media were purchased from Cytogen 
and fetal calf serum (FCS) from Gibco. L-glutamine, 
sodium pyruvate, 2-mercaptoethanol and antibiotics 
were from Sigma. Encephalomyocarditis virus (EMCV) 
was obtained from The Laboratory of Virology, Institute 
of Immunology and Experimental Therapy, Wrocław, 
Poland. L929 cells (ATCC CCL 1) was purchased from 
ATCC. We followed the procedures of preparation of 
splenocyte suspension and fractionation of splenocytes 
on glass wool columns which were described elsewhere 
(Russo et al., 1979). Such a procedure allowed to remove 
from the splenocyte suspension strongly adherent cells 
(macro phages), erythrocytes, debris and dead cells, as 
well as a part of T cell population, resulting in a B-cell 
enriched population. The determination of the cell phe-
notype of this fraction indicated (FACS measurement, 
not shown) that it was about 65–72% CD19 positive 
(a pan B cell marker). One of the reasons, we have cho-
sen such a  model, was because the activity of B cell 
compartment is well preserved in aged mice.
For the infection of cells we used EMCV, which was 
propagated and titrated in L929 cells. The titer of the 
virus was expressed in reference to the value of TCID50 
(tissue culture infectious dose), based on the cytopathic 
effect caused by the virus in 50% of infected cells. In the 
present study we applied two approaches to evaluate 
the protective effects of lactoferrins. In the first model, 
the cells were infected with the virus, followed by the 
addition of lactoferrins (50 μg/ml). The viral replication 
was determined after 24 h and 5 days of cell culture. 
In the second model, the cells (2 × 106/ml), re-suspended in 
the culture medium consisting of RPMI-1640 medium, 
10% of FCS, L-glutamine, sodium pyruvate, 2-mercapto-
ethanol and antibiotics, were incubated for 1 h at 37°C 
with the studied lactoferrins (50 μg/ml). Then, the cells 
were washed twice with Hanks’ medium, re-suspended 
in the culture medium and infected with EMCV. The 
Fig. 1. The effect of lactoferrins on EMCV replication in the B-cell enriched splenocyte population from young and old mice.
Lactoferrins (50 μg/ml) were added to the cells after EMCV adsorption. Samples of culture medium from LFs-treated and non-treated cells, incubated 




viral replication was determined after 5 days of culture. 
The cells were infected with a dose of 100 TCID50/ml of 
EMCV in a presence or absence of lactoferrins. After 
45 min of adsorption at 37°C, the virus was disposed 
by 5  times wash of the cells in Hanks’ medium. The 
infected cells were then re-suspended in the culture 
medium and transferred to a 96-well plate. After 24 h 
or 5 days of incubation at 37°C, samples of the super-
natants were collected and frozen at –20°C. The super-
natants were then thawed, serially diluted and plated 
in the presence of target L929 cells to determine the 
viral titer, indicated as the TCID50. For the statistical 
evaluation of the data, the analysis of variance (one-way 
ANOVA) was applied due to a homogeneity of variance 
between the groups, followed by post hoc comparisons 
with the Tukey’s test to estimate the significance of 
differences between the groups. The significance was 
determined at p < 0.05 and indicated as*. The results 
are presented as mean values ± standard error (SE). The 
result of one representative experiment was shown, out 
of three experiments performed.
The splenocytes from young and old mice were 
investigated for their susceptibility to viral infection. 
The effects of lactoferrins on these parameters were also 
determined. In one model, the cells were infected with 
the virus, washed and incubated with the lactoferrins 
for 24 h or 5 days (Fig. 1A-B), followed by determination 
of the virus titer. Thus, in this model, lactoferrin was 
designed to act solely as an inhibitor of virus replication. 
It appeared that after 24 h culture the rate of infection 
in cells from both young and old mice was the same 
(Fig. 1A). Both types of lactoferrins significantly reduced 
the virus titer in cells derived from young and old mice. 
The inhibitory effects of lactoferrins were stronger in 
young mice, particularly in the case of bLF. After 5-day 
exposure to the virus and the lactoferrins, the infection 
rates of cells from young and old mice were compara-
ble (Fig. 1B). The inhibitory effects of lactoferrins were 
stronger in young mice, both lactoferrins being equally 
active. On the other hand, the virus replication in old 
mice was significantly inhibited only by bLF. In the sec-
ond model the cells were incubated for 1 h with lactofer-
rins, washed and exposed to the virus for 5 days (Fig. 2) 
in order to test an ability of this protein to interfere with 
virus binding to the cells. The susceptibility of cell popu-
lations from both age categories was comparable. While 
the suppressive effects of bLF on the virus titers were 
statistically significant in both splenocyte populations, 
the action of rmLF was weaker and not significant.
Although we demonstrated more potent actions of 
bovine lactoferrin on resistance of splenocytes to viral 
infection, as compared to recombinant mouse lactofer-
rin, the efficacy of the homologous lactoferrin in the 
antiviral resistance was shown here for the first time. 
Small differences in the efficacy of bovive and mouse 
lactoferrin in the antiviral resistance of splenic B cells 
could be due to different structures of glycan moieties 
in the two types of lactoferrins. These structures are 
responsible for blocking CD21 receptors on B cells 
(Zheng et al., 2012) which are also used for viruses to 
enter cells. The heparan sulfate receptors for viruses are, 
in turn, blocked by a highly cationic N-terminal end of 
lactoferrin (Pietroantoni et al., 2015).
Our results on the suceptibility to viral infection 
in old versus young individuals are, in part, consist-
ent with a hypothesis (Scholz et al., 2013) that the viral 
resistance in the elderly may be even enhanced due 
to a cumulative, frequent contacts with viral antigens 
Fig. 2. Effect of preincubation of the B-cell enriched splenocytes from young and old mice, with lactoferrins on viral replication.
The cells were re-suspended in the culture medium and cultured with lactoferrins (50 μg/ml) for 1h at 37°C. After the incubation, the cells were 
washed twice with Hanks’ medium, re-suspended in the culture medium and infected with EMCV. Samples of culture medium were collected after 5 
days and titrated in L929 cells.
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resulting in a presence of a bigger pool of antigen-
specific memory cells. Although mouse (Scholz et al., 
2013; Zhang et al., 2002) and human studies (Labeur 
et al., 1991) indicated impaired susceptibility of aged 
organisms to viral infection, it is also clear (Dailey et al., 
2001; Castle et al., 1999) that the activation status and 
functional capacity of B cells from old mice are higher 
or at least not lower than those in young ones.
EMCV infects several cell types beside lymphocytes 
and the mechanisms of interference with virus replica-
tion by LF are probably common for most cell types. 
We also think that interference of other cell types and 
cytokines on the susceptibility of B cells to viral infec-
tion may be negligible. Besides, we obtained similar 
results with a T-cell-enriched cell fraction (not shown). 
In view of the literature on the protective role of 
lactoferrin in viral infection (Pietroantoni et al., 2015; 
Välimaa et al., 2009; Zheng et al., 2012) it was not unex-
pected that also in this study lactoferrins demonstrated 
antiviral properties in the applied models, i.e. potential 
block of virus receptors on target cells and interference 
with virus replication. We also suggest still another 
mechanism of the antiviral activity of lactoferrin, since 
the protein is an enhancer of COX-1 expression (Kruzel 
et al., 2013), important in maintaining antiviral resist-
ance (Carey et al., 2010). In addition, a lack of age-rela-
ted difference in COX-1 protein levels found by others 
(Hayek et al., 1997) further supports our findings on the 
comparable susceptibility to viral infection in both age 
categories. Our results provided also the evidence that 
the homologous (mouse lactoferrin) may play a physio-
logical role in the antiviral resistance in mice and that 
the protective effect of lactoferrin is not species specific. 
It was also encouraging to find that cells from old indi-
viduals were at least equally resistant to viral infection 
as those derived from young ones. In conclusion, we 
showed that the resistance to viral infection was pre-
served in the senescent mice. We also demonstrated, for 
the first time, the antiviral actions of the homologous 
mouse lactoferrin. Based on the results, regarding the 
protective effect of bovine lactoferrin on virally infected 
splenocytes from old mice, we also suggest a potential 
benefit of diet supplemented with bovine lactoferrin for 
the elderly in enhancing antiviral resistance.
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